Corebridge Financial’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,402	Closed	-$5.37K	–	1068
2025 Q1	$5.37K	Sell	4,402 -5,722	-57%	-$6.98K	﹤0.01%	2998
2024 Q4	$13.1K	Sell	10,124 -764	-7%	-$986	﹤0.01%	2993
2024 Q3	$29.9K	Sell	10,888 -67	-0.6%	-$184	﹤0.01%	2951
2024 Q2	$24.9K	Buy	+10,955	New	+$24.9K	﹤0.01%	2972